146 related articles for article (PubMed ID: 30017076)
1. In vitro antimicrobial activity of monensin against common clinical isolates associated with canine otitis externa.
Chan WY; Hickey EE; Khazandi M; Page SW; Trott DJ; Hill PB
Comp Immunol Microbiol Infect Dis; 2018 Apr; 57():34-38. PubMed ID: 30017076
[TBL] [Abstract][Full Text] [Related]
2. In vitro antimicrobial activity of narasin against common clinical isolates associated with canine otitis externa.
Chan WY; Hickey EE; Khazandi M; Page SW; Trott DJ; Hill PB
Vet Dermatol; 2018 Apr; 29(2):149-e57. PubMed ID: 29363210
[TBL] [Abstract][Full Text] [Related]
3. In vitro antimicrobial activity of narasin and monensin in combination with adjuvants against pathogens associated with canine otitis externa.
Chan WY; Hickey EE; Khazandi M; Page SW; Trott DJ; Hill PB
Vet Dermatol; 2020 Apr; 31(2):138-145. PubMed ID: 31710159
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial activity of thyme oil, oregano oil, thymol and carvacrol against sensitive and resistant microbial isolates from dogs with otitis externa.
Sim JXF; Khazandi M; Chan WY; Trott DJ; Deo P
Vet Dermatol; 2019 Dec; 30(6):524-e159. PubMed ID: 31566822
[TBL] [Abstract][Full Text] [Related]
5. Comparison of bacterial organisms and their susceptibility patterns from otic exudate and ear tissue from the vertical ear canal of dogs undergoing a total ear canal ablation.
Cole LK; Kwochka KW; Hillier A; Kowalski JJ; Smeak DD
Vet Ther; 2005; 6(3):252-9. PubMed ID: 16299671
[TBL] [Abstract][Full Text] [Related]
6. Biofilm production by pathogens associated with canine otitis externa, and the antibiofilm activity of ionophores and antimicrobial adjuvants.
Chan WY; Hickey EE; Page SW; Trott DJ; Hill PB
J Vet Pharmacol Ther; 2019 Nov; 42(6):682-692. PubMed ID: 31503362
[TBL] [Abstract][Full Text] [Related]
7. In vitro antibacterial activity of the manuka essential oil from Leptospermum scoparium combined with Tris-EDTA against Gram-negative bacterial isolates from dogs with otitis externa.
Song SY; Hyun JE; Kang JH; Hwang CY
Vet Dermatol; 2020 Apr; 31(2):81-85. PubMed ID: 31729809
[TBL] [Abstract][Full Text] [Related]
8. In vitro antimicrobial activity of seven adjuvants against common pathogens associated with canine otitis externa.
Chan WY; Khazandi M; Hickey EE; Page SW; Trott DJ; Hill PB
Vet Dermatol; 2019 Apr; 30(2):133-e38. PubMed ID: 30548715
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of bacterial isolates from chronic canine otitis externa to twenty antibiotics.
Guedeja-Marrón J; Blanco JL; Ruperez C; Garcia ME
Zentralbl Veterinarmed B; 1998 Oct; 45(8):507-12. PubMed ID: 9820118
[TBL] [Abstract][Full Text] [Related]
10. Carriage of
Lee GY; Lee HH; Hwang SY; Hong J; Lyoo KS; Yang SJ
J Vet Sci; 2019 Mar; 20(2):e6. PubMed ID: 30944529
[TBL] [Abstract][Full Text] [Related]
11. Development of resistant bacteria isolated from dogs with otitis externa or urinary tract infections after exposure to enrofloxacin in vitro.
Brothers AM; Gibbs PS; Wooley RE
Vet Ther; 2002; 3(4):493-500. PubMed ID: 12584687
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial effect of N-acetylcysteine on common canine otitis externa isolates.
May ER; Conklin KA; Bemis DA
Vet Dermatol; 2016 Jun; 27(3):188-e47. PubMed ID: 27122224
[TBL] [Abstract][Full Text] [Related]
13. Effect of tympanic cavity evacuation and flushing on microbial isolates during total ear canal ablation with lateral bulla osteotomy in dogs.
Hettlich BE; Boothe HW; Simpson RB; Dubose KA; Boothe DM; Carpenter M
J Am Vet Med Assoc; 2005 Sep; 227(5):748-55. PubMed ID: 16178396
[TBL] [Abstract][Full Text] [Related]
14. The joint in vitro action of polymyxin B and miconazole against pathogens associated with canine otitis externa from three European countries.
Pietschmann S; Meyer M; Voget M; Cieslicki M
Vet Dermatol; 2013 Aug; 24(4):439-45, e96-7. PubMed ID: 23721182
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial sensitivity in microorganisms isolated from canine otitis externa.
Guedeja-Marron J; Blanco JL; Garcia ME
Zentralbl Veterinarmed B; 1997 Aug; 44(6):341-6. PubMed ID: 9283285
[TBL] [Abstract][Full Text] [Related]
16.
Gómez-García M; Madrigal I; Puente H; Mencía-Ares Ó; Argüello H; Carvajal A; Fregeneda-Grandes JM
Nat Prod Res; 2022 Sep; 36(17):4552-4556. PubMed ID: 34672232
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial.
Morfin-Otero R; Noriega ER; Dowzicky MJ
Ann Clin Microbiol Antimicrob; 2015 Dec; 14():53. PubMed ID: 26667651
[TBL] [Abstract][Full Text] [Related]
18. Identification and antimicrobial susceptibility of bacteria and yeasts isolated from healthy dogs and dogs with otitis externa.
Lyskova P; Vydrzalova M; Mazurova J
J Vet Med A Physiol Pathol Clin Med; 2007 Dec; 54(10):559-63. PubMed ID: 18045339
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.
Vega S; Dowzicky MJ
Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):50. PubMed ID: 28701170
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic susceptibility of bacteria isolated from infections in cats and dogs throughout Europe (2002-2009).
Kroemer S; El Garch F; Galland D; Petit JL; Woehrle F; Boulouis HJ
Comp Immunol Microbiol Infect Dis; 2014 Mar; 37(2):97-108. PubMed ID: 24447508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
